In the News

CABG may improve outcomes compared with PCI in patients with diabetes and stable CAD

The results support coronary artery bypass grafting (CABG) with optimal medical therapy as the preferred management strategy, with optimal medical therapy alone as the next best therapeutic approach, the study authors said.

Intense multifactorial intervention associated with increased life span, time to CVD events in type 2 diabetes

The intensive intervention was initially conducted for a median of 7.8 years and used both pharmacologic and behavioral methods to target coexisting risk factors for late complications of diabetes.

Restricting orders for insulin glargine may lower hypoglycemia rates, study finds

Non-endocrinologist clinicians who electronically ordered glargine at a dose of 0.5 units/kg or greater incurred a warning screen, which advised either lowering the dose or contacting the diabetes consult service for approval.

MKSAP Quiz: Diabetes and hyperlipidemia

This month's quiz asks readers to treat hyperlipidemia in a 67-year-old man with a recent diagnosis of type 2 diabetes mellitus.

Review: In type 2 diabetes, adding dipeptidyl peptidase-4 inhibitors to sulfonylureas increases hypoglycemia

Adding dipeptidyl peptidase-4 (DPP-4) inhibitors to sulfonylureas was associated with 1 excess case of hypoglycemia for every 17 patients in the first 6 months of treatment, the systematic review and meta-analysis found.

Preoperative factors may help predict long-term weight outcomes after gastric bypass, study finds

Only 3 factors were associated with greater long-term weight loss: preoperative insulin use, history of smoking, and use of 12 or more medications before surgery.

System-wide changes improve diabetes care

A Success Story in the latest issue of ACP Internist describes a primary care intervention to improve HbA1c testing.

Glucagon recalled due to detaching needles

Six batches of GlucaGen HypoKit (glucagon [rDNA origin] for injection) were recalled due to the possibility of needle detachment, the FDA recently announced.

Spotlight on undertreatment of risks from diabetes

Studies published in the past month looked at statin prescriptions for patients with diabetes and osteoporotic fracture risk in women with diabetes.